Vallance, J. H. (2012). Comment on ‘Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: Ranibizumab and bevacizumab'. Nature Publishing Group.
Chicago Stili AlıntıVallance, J H. Comment On ‘Preclinical Aspects of Anti-VEGF Agents for the Treatment of Wet AMD: Ranibizumab and Bevacizumab'. Nature Publishing Group, 2012.
MLA AlıntıVallance, J H. Comment On ‘Preclinical Aspects of Anti-VEGF Agents for the Treatment of Wet AMD: Ranibizumab and Bevacizumab'. Nature Publishing Group, 2012.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..